Medical Ikkou Group Co.,Ltd. (TYO:3353)
Japan · Delayed Price · Currency is JPY 2,772.00
-1.00 (-0.04%)
Oct 22, 2026, 1:11 PM JST
Medical Ikkou Group Financials Overview
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Revenue Revenue Growth | 56,302 | 54,982 | 48,393 | 39,900 | 33,897 | 33,595 |
Revenue Growth | 6.91% | 13.62% | 21.29% | 17.71% | 0.90% | 6.30% |
Gross Profit Gross Profit Growth | 6,598 | 6,485 | 5,744 | 4,551 | 3,182 | 3,613 |
Operating Income Operating Income Growth | 1,865 | 1,788 | 1,692 | 1,559 | 935 | 1,275 |
Net Income Net Income Growth | 1,459 | 1,275 | 1,133 | 1,039 | 759 | 852 |
Earnings Per Share EPS Growth | 387.43 | 338.72 | 301.31 | 276.50 | 202.04 | 226.83 |
EPS Growth | 33.72% | 12.41% | 8.97% | 36.85% | -10.93% | 2.37% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Dispensing Pharmacy Business Dispensing Pharmacy Business Growth | 26,291 | 24,710 | 23,537 | 23,095 | 22,731 |
Unallocated Adjustment Unallocated Adjustment Growth | -1,206 | -845.79 | -879.15 | -1,000 | -1,075 |
Real Estate Business Real Estate Business Growth | 265.28 | 208.4 | 185.64 | 189.05 | 233.2 |
Wholesale of Pharmaceuticals Business Wholesale of Pharmaceuticals Business Growth | 20,641 | 16,198 | 9,310 | 3,942 | 3,892 |
Healthcare Business Healthcare Business Growth | 8,991 | 8,122 | 7,748 | 7,672 | 7,814 |
Total Total Growth | 54,983 | 48,393 | 39,901 | 33,898 | 33,596 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Cash & Investments Cash & Investments Growth | 7,512 | 6,121 | 6,768 | 7,700 | 6,443 | 7,992 |
Total Debt Total Debt Growth | 9,458 | 10,363 | 10,016 | 9,577 | 9,115 | 11,311 |
Net Cash (Debt) Net Cash Growth | -1,946 | -4,242 | -3,248 | -1,877 | -2,672 | -3,319 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -516.75 | -1126.93 | -863.77 | -499.51 | -711.27 | -883.64 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,188 | 1,208 | 1,198 | 4,277 | 1,307 | 1,135 |
Capital Expenditures CapEx Growth | -397 | -526 | -996 | -302 | -311 | -322 |
Free Cash Flow Free Cash Flow Growth | 1,791 | 682 | 202 | 3,975 | 996 | 813 |
Free Cash Flow Growth | 405.93% | 237.62% | -94.92% | 299.10% | 22.51% | -39.87% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Gross Margin | 11.72% | 11.79% | 11.87% | 11.41% | 9.39% | 10.76% |
Operating Margin | 3.31% | 3.25% | 3.50% | 3.91% | 2.76% | 3.79% |
Pretax Margin | 4.17% | 3.68% | 3.93% | 4.16% | 3.87% | 4.39% |
Profit Margin | 2.59% | 2.32% | 2.34% | 2.60% | 2.24% | 2.54% |
FCF Margin | 3.18% | 1.24% | 0.42% | 9.96% | 2.94% | 2.42% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Dividend Per Share Dividend Per Share Growth | 120.000 | 120.000 | 60.000 | 45.000 | 40.000 | 40.000 |
Dividend Per Share Growth | 0% | 100.00% | 33.33% | 12.50% | 0% | -50.00% |
Dividend Yield | 4.33% | 3.93% | 2.73% | 1.93% | 1.54% | 1.57% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
PE Ratio | 7.15 | 9.01 | 7.30 | 8.45 | 12.82 | 11.24 |
P/FCF Ratio | 5.83 | 16.84 | 40.97 | 2.21 | 9.77 | 11.78 |
PS Ratio | 0.19 | 0.21 | 0.17 | 0.22 | 0.29 | 0.28 |